| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥9.6B | ¥11.8B | -19.3% |
| Operating Income | ¥-2.0B | ¥-0.6B | -47.6% |
| Ordinary Income | ¥-1.6B | ¥-0.2B | -46.0% |
| Net Income | ¥-1.1B | ¥-1.4B | +19.3% |
| ROE | -1.2% | -1.4% | - |
FY2026 Q1 consolidated results under JGAAP showed revenue of 9.6B yen (down 19.3% YoY), operating loss of 2.0B yen (loss expanded by 47.6% YoY), ordinary loss of 1.6B yen (loss expanded by 46.0% YoY), and net loss of 1.1B yen (loss narrowed by 19.3% YoY). Gross profit margin declined to 13.4% from approximately 23.2% in the prior year period, while operating margin deteriorated to negative 21.4% from negative 4.8%, representing approximately 1,640 basis points of deterioration. All three reporting segments recorded operating losses, with Electronic Equipment business showing particularly severe loss expansion. Despite continued losses, cash and deposits stood at 50.3B yen with a current ratio of 225.3%, maintaining surface-level liquidity. However, concentration of 41.0B yen in short-term borrowings presents refinancing considerations.
Revenue declined 19.3% to 9.6B yen, driven by decreases across all three segments. Electronic Equipment business revenue fell 20.9% to 860M yen, Textile Equipment sales increased 54.3% to 29M yen, and Medical Equipment sales declined 15.3% to 66M yen. The revenue decline reflects a combination of demand weakness and unfavorable product mix. Gross profit margin compression from 23.2% to 13.4% indicates either pricing pressure or increased cost structure relative to sales, contributing to the severity of operating loss expansion. Operating loss expanded from 57M yen to 206M yen, primarily due to insufficient gross profit to absorb fixed costs. All three segments reported deeper operating losses: Electronic Equipment segment loss expanded from 40M yen to 152M yen, Textile Equipment loss narrowed from 9M yen to 5M yen, and Medical Equipment loss expanded from 9M yen to 49M yen. SG&A expenses of 3.3B yen represented 34.9% of sales, suggesting fixed cost absorption deteriorated significantly with volume decline. The gap between operating loss of 2.0B yen and ordinary loss of 1.6B yen reflects 423M yen of non-operating net income, including dividend income of 13M yen and foreign exchange gains of 16M yen, partially offsetting interest expense of 8M yen. Net loss of 1.1B yen versus ordinary loss of 1.6B yen indicates approximately 490M yen of tax benefit recognition. No extraordinary items such as impairment, asset sales, or restructuring were reported. The company exhibits a revenue down/profit down pattern, with profitability deterioration exceeding the magnitude of revenue decline due to operating leverage effects and margin compression.
Electronic Equipment business represents the core segment, generating 860M yen in revenue (89.9% of total) but recording an operating loss of 152M yen, with loss deepening substantially from 40M yen in the prior year. This segment's operating margin of negative 17.7% represents significant deterioration. Medical Equipment business generated 66M yen in revenue (6.9% of total) with an operating loss of 49M yen, showing a negative 73.1% margin and representing the worst margin performance among segments. Textile Equipment business contributed 29M yen in revenue (3.1% of total) with an operating loss of 5M yen, representing a negative 17.9% margin but showing improvement from the prior year loss of 9M yen. The Electronic Equipment segment's dominance in revenue composition combined with significant loss expansion indicates that core business performance recovery is the critical driver for overall profitability improvement. Material margin differences exist across segments, with Medical Equipment showing particularly severe operational challenges relative to its revenue base.
[Profitability] ROE of negative 1.2% reflects persistent losses, operating margin of negative 21.4% deteriorated from negative 4.8% YoY representing approximately 1,640 basis points of decline, gross profit margin of 13.4% compressed from approximately 23.2% YoY indicating pricing pressure or cost structure challenges, and net profit margin of negative 11.8% reflects bottom-line weakness. [Cash Quality] Cash and deposits of 50.3B yen provide 1.23 times coverage of short-term borrowings of 41.0B yen, interest coverage ratio of negative 26.13 times indicates operating losses relative to interest expense of 8M yen with an interest burden coefficient of 0.795. [Investment Efficiency] Total asset turnover of 0.062 times annually reflects slow asset utilization, with DuPont decomposition showing ROE driven by net profit margin of negative 11.8%, asset turnover of 0.062, and financial leverage of 1.57 times. [Financial Health] Equity ratio of 63.5% reflects conservative capital structure, current ratio of 225.3% and quick ratio of 225.3% indicate adequate short-term liquidity, debt-to-equity ratio of 0.57 times with debt-to-capital of 29.6% shows moderate leverage, though short-term debt represents 100% of total borrowings creating refinancing considerations.
Cash and deposits of 50.3B yen represent adequate coverage of short-term borrowings at 41.0B yen, providing 1.23 times short-term debt coverage despite operating losses. Working capital indicators show accounts receivable declined significantly by 36.2% YoY from 21.8B yen to 13.9B yen, potentially reflecting both sales volume decline and collection acceleration. Inventory levels of raw materials at 39.2B yen and work-in-process at 15.9B yen represent substantial working capital tied up in operations, with industry metrics flagging elevated inventory days. Current assets of 125.0B yen versus current liabilities of 55.5B yen provide a 2.25 times coverage ratio, confirming adequate near-term liquidity buffers. The balance sheet structure shows treasury stock increased from 0.3B yen to 2.2B yen, indicating share repurchase activity during the period. Total equity declined from 102.7B yen to 97.6B yen, reflecting the net loss impact on retained earnings, while total assets decreased from 159.1B yen to 153.6B yen driven by working capital adjustments.
Ordinary loss of 1.6B yen versus operating loss of 2.0B yen shows net non-operating contribution of approximately 423M yen, comprising dividend income of 13M yen, foreign exchange gains of 16M yen, and other financial income partially offset by interest expense of 8M yen. Non-operating income represents approximately 4.4% of revenue, primarily consisting of financial and investment income streams. The difference between ordinary loss and net loss of approximately 490M yen reflects tax benefit recognition, which provides some earnings support despite pre-tax losses. Operating cash flow data is not disclosed for the quarterly period, limiting assessment of cash-backed earnings quality. However, the significant deterioration in operating margin from negative 4.8% to negative 21.4% combined with gross margin compression from 23.2% to 13.4% suggests core operational challenges rather than timing or accrual differences. The substantial decline in accounts receivable by 7.9B yen while sales declined only 2.3B yen on a quarterly basis indicates possible collection acceleration or revenue mix changes that warrant monitoring for earnings sustainability.
Full-year guidance of revenue 70.0B yen, operating income 4.3B yen, and ordinary income 4.6B yen implies Q1 progress rates of 13.7% for revenue, negative for operating income, and negative for ordinary income. These progress rates fall substantially below the standard 25% Q1 benchmark, indicating significant underperformance relative to full-year expectations. Revenue shortfall of approximately 11 percentage points from standard progress suggests either pronounced seasonality or delayed recovery in order intake. The transition from Q1 operating loss of 2.0B yen to full-year operating income guidance of 4.3B yen requires approximately 6.3B yen of cumulative improvement over the remaining three quarters, or approximately 2.1B yen per quarter on average. This implies substantial margin recovery and revenue acceleration must materialize to achieve guidance. Contract liabilities of 0.7B yen provide limited forward revenue visibility, representing approximately 1.0% of full-year revenue guidance. The backlog-to-revenue ratio indicates minimal near-term revenue visibility, suggesting reliance on new order intake for guidance achievement. No specific assumptions or revised guidance details were disclosed, creating uncertainty around the recovery trajectory required for full-year target attainment.
Annual dividend forecast of 0 yen for the interim period and 40 yen for the year-end represents total planned annual dividend of 40 yen per share. Based on average outstanding shares of 5,376K and net loss of 1.1B yen, the calculated payout ratio is negative 194.4%, reflecting dividends paid from retained earnings despite current period losses. This indicates the dividend is not supported by current earnings and relies on accumulated capital or cash reserves. With cash and deposits of 50.3B yen and total planned dividend payments of approximately 219M yen (40 yen times approximately 5.49M shares outstanding), the company maintains 230 times cash coverage of the planned dividend, confirming short-term payment capacity. Share repurchase activity is evident from treasury stock increase from 0.3B yen to 2.2B yen, representing approximately 1.9B yen of buyback activity. Combined dividends and buybacks imply total potential capital return, though specific buyback completion details are not fully disclosed. The sustainability of this dividend policy requires either return to profitability per full-year guidance or continued draw from cash reserves, with medium-term sustainability dependent on operational recovery.
Revenue concentration risk in Electronic Equipment segment at 89.9% of total sales with severe operating loss of 152M yen creates vulnerability, as core business deterioration of 20.9% revenue decline and margin compression directly impacts consolidated profitability with limited diversification benefits. Refinancing risk from 41.0B yen of short-term borrowings representing 100% of debt concentration creates liquidity pressure, requiring either debt extension negotiations or operational cash generation for refinancing, particularly given operating losses of 2.0B yen that strain cash flow coverage. Margin compression risk evident in gross margin decline from 23.2% to 13.4% representing 880 basis points of deterioration suggests pricing pressure or cost structure challenges, with operating margin negative 21.4% requiring substantial recovery to positive territory for full-year guidance of 4.3B yen operating income, implying approximately 300 basis points of quarterly margin improvement needed across remaining periods.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE of negative 1.2% substantially underperforms the manufacturing industry median of 3.1% for 2025 Q1, with the company falling below the 25th percentile of the 2.0%-4.9% interquartile range. Operating margin of negative 21.4% is significantly below the industry median of 6.8% (IQR: 2.9%-9.0%), representing approximately 2,800 basis points of underperformance and indicating severe operational challenges relative to peers. Net profit margin of negative 11.9% compares unfavorably to industry median of 5.9% (IQR: 3.3%-7.7%). Financial Health: Equity ratio of 63.5% exceeds the industry median of 43.9% (IQR: 28.4%-50.7%), placing the company in the upper quartile for capital strength and demonstrating conservative financial structure. Current ratio of 2.25 times aligns with industry median of 1.87 times (IQR: 1.86x-2.23x), confirming adequate liquidity positioning relative to peer group. Efficiency: Revenue growth of negative 19.3% underperforms the industry median of positive 13.2% (IQR: 2.5%-28.5%), representing approximately 3,200 basis points of underperformance and placing the company well below the 25th percentile. Asset turnover of 0.062 falls below the industry median of 0.17 (IQR: 0.16-0.23), indicating relatively slower asset utilization efficiency. (Industry: Manufacturing (8 companies), Comparison: FY2025 Q1 period, Source: Proprietary analysis)
Significant operational turnaround requirement is evident from Q1 results showing operating loss of 2.0B yen and negative 21.4% operating margin, requiring approximately 6.3B yen of cumulative profit improvement across remaining three quarters to achieve full-year operating income guidance of 4.3B yen, implying margin recovery of approximately 300 basis points quarterly. Financial position strength provides buffer for operational recovery execution, with equity ratio of 63.5% exceeding industry median by approximately 2,000 basis points and cash position of 50.3B yen providing 1.23 times coverage of short-term debt, though 100% concentration in short-term borrowings requires refinancing attention. Core business deterioration in Electronic Equipment segment showing revenue decline of 20.9% and operating loss expansion from 40M yen to 152M yen represents the critical recovery lever, as this segment comprises 89.9% of total revenue, with visibility dependent on order intake acceleration and margin restoration through either pricing recovery or cost structure realignment.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.